Sofinnova Investments Inc. Has 21.02 Million Position in CTI BioPharma Corp.
| CTICDelisted Stock | USD 9.09 0.00 0.00% |
About 56% of CTi Biopharma's investor base is looking to short. The analysis of current outlook of investing in CTi Biopharma Corp suggests that many traders are alarmed regarding CTi Biopharma's prospects. The current market sentiment, together with CTi Biopharma's historical and current headlines, can help investors time the market. In addition, many technical investors use CTi Biopharma Corp stock news signals to limit their universe of possible portfolio assets.
CTi |
Sofinnova Investments Inc. increased its position in shares of CTI BioPharma Corp. by 33.6 percent in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,612,376 shares of the biopharmaceutical companys stock after purchasing an additional 907,866 shares during
Read at thelincolnianonline.com
 |
CTi Biopharma Fundamental Analysis
We analyze CTi Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CTi Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CTi Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
CTi Biopharma is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
CTi Biopharma Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CTi Biopharma stock to make a market-neutral strategy. Peer analysis of CTi Biopharma could also be used in its relative valuation, which is a method of valuing CTi Biopharma by comparing valuation metrics with similar companies.
Peers
CTi Biopharma Related Equities
| XFOR | X4 Pharmaceuticals | 13.54 | ||||
| RVPH | Reviva Pharmaceuticals | 11.90 | ||||
| IMMP | Immutep | 11.32 | ||||
| VKTX | Viking Therapeutics | 2.84 | ||||
| CRVS | Corvus Pharmaceuticals | 1.12 | ||||
| TGTX | TG Therapeutics | 0.06 | ||||
| CDTX | Cidara Therapeutics | 1.58 | ||||
| PLX | Protalix Biotherapeutics | 1.64 | ||||
| VSTM | Verastem | 1.80 | ||||
| MDGL | Madrigal Pharmaceuticals | 1.99 | ||||
| PDSB | PDS Biotechnology | 2.80 | ||||
| FBIO | Fortress Biotech | 2.83 | ||||
| MCRB | Seres Therapeutics | 3.23 | ||||
| ELEV | Elevation Oncology | 4.00 | ||||
| RIGL | Rigel Pharmaceuticals | 5.01 | ||||
| IBRX | Immunitybio | 32.11 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in CTi Stock
If you are still planning to invest in CTi Biopharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CTi Biopharma's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |